User login
CHICAGO – Dr. Laurie J. McKenzie, who is a member of the ACOG Committee on the Scientific Program and the medical faculties of the University of Texas and Baylor College of Medicine, Houston, interviews Dr. Michael M. Frumovitz of the University of Texas MD Anderson Cancer Center, Houston, the presenter of the John I. Brewer Memorial Lecture on cervical cancer screening.
During a video interview at the annual meeting of the American Congress of Obstetricians and Gynecologists, they discuss reductions in cervical dysplasia that have already been seen with HPV vaccination in Australia and note the barriers to HPV vaccination in the United States. Dr. Frumovitz predicts that HPV testing will ultimately replace Pap smears for primary screening in most cases and discusses the potential for high-resolution microendoscopy to change how cervical lesions are diagnosed and treated.
CHICAGO – Dr. Laurie J. McKenzie, who is a member of the ACOG Committee on the Scientific Program and the medical faculties of the University of Texas and Baylor College of Medicine, Houston, interviews Dr. Michael M. Frumovitz of the University of Texas MD Anderson Cancer Center, Houston, the presenter of the John I. Brewer Memorial Lecture on cervical cancer screening.
During a video interview at the annual meeting of the American Congress of Obstetricians and Gynecologists, they discuss reductions in cervical dysplasia that have already been seen with HPV vaccination in Australia and note the barriers to HPV vaccination in the United States. Dr. Frumovitz predicts that HPV testing will ultimately replace Pap smears for primary screening in most cases and discusses the potential for high-resolution microendoscopy to change how cervical lesions are diagnosed and treated.
CHICAGO – Dr. Laurie J. McKenzie, who is a member of the ACOG Committee on the Scientific Program and the medical faculties of the University of Texas and Baylor College of Medicine, Houston, interviews Dr. Michael M. Frumovitz of the University of Texas MD Anderson Cancer Center, Houston, the presenter of the John I. Brewer Memorial Lecture on cervical cancer screening.
During a video interview at the annual meeting of the American Congress of Obstetricians and Gynecologists, they discuss reductions in cervical dysplasia that have already been seen with HPV vaccination in Australia and note the barriers to HPV vaccination in the United States. Dr. Frumovitz predicts that HPV testing will ultimately replace Pap smears for primary screening in most cases and discusses the potential for high-resolution microendoscopy to change how cervical lesions are diagnosed and treated.
EXPERT ANALYSIS AT THE ACOG ANNUAL CLINICAL MEETING
